Navigation Links
NEW POLL: Tennessee Voters Strongly Oppose Making Popular Cold and Allergy Meds Prescription Only
Date:2/13/2013

WASHINGTON, Feb. 13, 2013 /PRNewswire/ -- Tennessee voters, by a 20-point margin (56 to 36 percent), oppose making common cold and allergy medications containing pseudoephedrine (PSE) available by prescription (Rx) only, and nearly two-thirds of respondents (61 percent) who use nonprescription cold and allergy medicines to treat symptoms oppose the proposal.  The new poll, which was conducted by North Star Opinion Research and released today by the Consumer Healthcare Products Association (CHPA), also found that nearly three-fifths of Tennessee voters (57%) believe the state's current anti-meth law, which utilizes real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx), is effective and should be given time to work. Just 33% say the law should be changed.

The new poll comes as Tennessee lawmakers are considering a proposal (House Bill 368) introduced by Representative David Hawk (R-Greeneville) that would require all Tennesseans to obtain a doctor's prescription before buying safe and effective medicines containing PSE. In addition to the clear majority of Tennessee voters, a number of prominent Tennessee groups, including the Tennessee Pharmacists Association and the Tennessee Chamber of Commerce and Industry, oppose the measure because it would produce a number of unnecessary burdens for law-abiding consumers, healthcare providers, retailers, and the state as a whole.

"Today's polling results clearly affirm that law-abiding Tennesseans prefer responsible solutions to the methamphetamine problem that don't make timely access to a wide range of over-the-counter treatment options harder to come by," said Carlos Gutierrez , senior director of state government affairs for CHPA. "There's no question that Tennessee still faces an uphill battle against meth production and abuse, but it's critically important for state leaders to give electronic tracking technology time to work. A prescription mandate would take away a vital tool for tracking and blocking suspicious purchasing activity."

In January 2012, Tennessee adopted a real-time, stop-sale pseudoephedrine tracking system, NPLEx. The proven system, fully operational in 25 states around the country, allows retailers to automatically block unlawful attempted purchases right at the sales counter. Law enforcement officials, in turn, can track suspicious purchasing activity and collect evidence against suspected meth cooks and dealers. In a little more than one year since implementation, Tennessee's system has already led directly to thousands of blocked pseudoephedrine sales and numerous meth lab seizures and arrests. Because it targets meth criminals, NPLEx ensures that responsible Tennessee workers and families will continue to have access to the cold and allergy medicines of their choice. As the new poll makes clear, a strong majority of Tennessee voters favors balanced legislation that won't impose higher costs and other burdens for honest citizens.

The poll was conducted February 4-6, 2013 and included interviews of 600 registered Tennessee voters. The poll has a margin of error of ± 4.00 percent.

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

www.chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tennessee Stop-Sale System Achieves Significant Results In Battle Against Meth
2. US Peripheral Vascular Device Market to Grow Strongly to $3.3 Billion by 2017
3. US Orthopedic Biomaterial Market to Grow Strongly to $3.7 Billion by 2017
4. National Patients Rights Association Opposes House Bill 5681 As A Result Of Potential Risks To Caregiver System
5. Survey: Medicare Beneficiaries Oppose Mandatory Mail Drug Plans
6. AdvaMed Opposes Puerto Rico Medical Device Tax Increase
7. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
8. Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution
9. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
10. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
11. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):